NEXT EVENTS:

COVID-19 Articles

EADV is closely monitoring the ongoing coronavirus pandemic. As the situation continues to change rapidly, our top priority remains the health, safety, and well-being of our community.

We will continue to share knowledge and information through our channels.

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals Kluger N. J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690 SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint? Rongioletti F. J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738 Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720 Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R. J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953. Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A. J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956 SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381 SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations B Cribier, C Taieb, M Saint Aroman, J Shourick J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380 Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450 Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640 Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970 Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062 Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690 A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases N. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738 Reply to ‘Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study’. by Bawane J et al L. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720 Face mask-induced purpura: another unexpected effect of COVID era V. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392 Effects of COVID-19 pandemic on malignant melanoma diagnosis Alessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545 Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us Juliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547
Cutaneous manifestations in COVID‐19: a first perspective Recalcati, S. J Eur Acad Dermatol Venereol. 2020 Mar 26. doi: 10.1111/jdv.16387 Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16470 Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S. Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. J Eur Acad Dermatol Venereol. 2020 Apr 21. doi: 10.1111/jdv.16519 Cutaneous manifestations in COVID-19: a new contribution Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16474 COVID-19 and cutaneous manifestations Mungmungpuntipantip R, Wiwanitkit V. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16483 A distinctive skin rash associated with Coronavirus Disease 2019? Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16471 Urticarial eruption in COVID-19 infection Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16472 Viral exanthem in COVID-19, a clinical enigma with biological significance Su CJ, Lee CH. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16469 Cutaneous manifestation of COVID-19 in images: A case report Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16531 Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16530 Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection van Damme C, Berlingin E, Saussez S, Accaputo O. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16523 Did Whatsapp® reveal a new cutaneous COVID-19 manifestation? Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16534 Acral cutaneous lesions in the time of COVID-19 Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16533 SARS-CoV-2 infection presenting as a febrile rash Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16528 Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16526 Symmetric cutaneous vasculitis in COVID-19 pneumonia Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16589 Vascular skin symptoms in COVID-19: a french observational study Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M. J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16544 Histological pattern in Covid-19 induced viral rash Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V. J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16569 Acro-ischemia in hospitalized COVID-19 patients Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16592 Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Ehsani AH, Nasimi M, Bigdelo Z. J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16579 The use of Google trends for acral symptoms during COVID-19 outbreak in France Kluger N, Scrivener Y. J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16572 Drug-induced vasculitis in a patient with COVID-19 Ramirez AV, Efe D, Fischer M. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16588 A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect? Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C. J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16633 Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 Janah H, Zinebi A, Elbenaye J. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16623 Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia Gunawan C, Angela, Widysanto A. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16622 A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y. J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16631 Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16613 Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16618 Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16617 Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients? Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S. J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16636 Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions? Goldust M, Abdelmaksoud A, Shuang Z, Xiang C, Navarini AA. J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16639 Chilblain acral lesions in the COVID -19 era. Are they marker of infection in asymptomatic patients? Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S. J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.166636 Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report Mayor-Ibarguren A, Feito-Rodriguez M, Quintana Castanedo L, Ruiz-Bravo E, Montero Vega D, Herranz-Pinto P. J Eur Acad Dermatol Venereol. 2020 May 22 doi: 10.1111/jdv.16670 A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue I. Torres‐Navarro, C. Abril‐Pérez, J. Roca‐Ginés, J. Sánchez‐Arráez, R. Botella‐Estrada J Eur Acad Dermatol Venereol. 2020 May 26;10.1111/jdv.16664. doi: 10.1111/jdv.16664 Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M, Gupta S. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16710 Urticaria (angioedema) and COVID- 19 infection Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A. J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16721. [Epub ahead of print]. Case report No antibody response in acral cutaneous manifestations associated with COVID-19? Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM. J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16688 Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M. J Eur Acad Dermatol Venereol. 2020 May 20. doi: 10.1111/jdv.16644 Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19 Guarneri C, Venanzi Rullo E, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G. J Eur Acad Dermatol Venereol. 2020 May 22. doi: 10.1111/jdv.16669 Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blasco P, Suarez-Valle A. J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16663 Late onset of acral necrosis after SARS-CoV-2 infection resolution Balestri R, Termine S, Rech G, Girardelli CR. J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16668 COVID-19 Presenting with Atypical Sweet’s Syndrome Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, Ferhanoğlu B, Alper S. J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16662 Acro-ischemia and COVID-19 infection: clinical and histopathological features Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC. J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16687 COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy Gaspari V, Neri I, Misciali C, Patrizi A. J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16693 The red half moon nail sign: a novel manifestation of Coronavirus infection Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16747 Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E. J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16666 Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de E, la Torre-Ruiz, Laínez-Nuez A, Suárez-Fernández R, Bergón-Sendín M. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16709 Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection Annunziata MC, Patrì A, Ruggiero A, Di Guida A, Menicanti C, Greco V, Fabbrocini G. J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16769 The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto JL, Ortiz-Romero PL, Rivera-Díaz R. J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16734 Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like” Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, Droy-Dupré L. J Eur Acad Dermatol Venereol. 2020 Jun 5. doi: 10.1111/jdv.16706 Covid-19 and outbreak of chilblains: are they related? Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D. J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16779 Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report Hashizume H, Sano Y, Furukawa S, Imokawa S. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16705 Retiform purpura as a dermatological sign of COVID-19 coagulopathy Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr. J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16689 COVID-19 Lockdown induced acral dermatosis in children Bodak N, Chiaverini C, Barbarot S. J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16797 A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R. J Eur Acad Dermatol Venereol. 2020 May 31. doi: 10.1111/jdv.16682 Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L. J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16733 Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16751 An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient Negrini S, Guadagno A, Greco M, Parodi A, Burlando M. J Eur Acad Dermatol Venereol. 2020 Jun 19. doi: 10.1111/jdv.16760 COVID-19 and cutaneous manifestations: A systematic review Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F. J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16778 Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE, Eshaq M, Renati S, Nikle AB, Allen A, Hawkins SD, Huerta T, Lowe L, Andea AA. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16741 Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A. J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16732 Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fernández-Guarino M. J Eur Acad Dermatol Venereol. 2020 Jun 8. doi: 10.1111/jdv.16713 A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 Caputo V, Schroeder J, Rongioletti F. J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16737 Cutaneous autoimmune diseases during COVID 19 pandemic Günther C, Aschoff R, Beissert S J Eur Acad Dermatol Venereol. 2020 Jun 13.doi.org/10.1111/jdv.16753 Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection Verheyden M, Grosber M, Gutermuth J, Velkeniers B. J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16773 Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients Reymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Llamas-Velasco M. J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16707 Cutaneous manifestations of SARS-CoV-2 infection: a clinical update Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16774 COVID-19-related acute genital ulcers Falkenhain-López D, Agud-Dios M, Ortiz-Romero PL, Sánchez-Velázquez A. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16740 SARS-CoV-2, skin lesions and the need of a multidisciplinary approach Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, Fernández-Guarino M, Fernández-Nieto D, Ortega-Quijano D, de-Andrés-Martín A, Moreno C, Carretero-Barrio I, García-Abellás P, González-de-Olano D, de-la-Hoz-Caballer B. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16745 Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V. J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16749 Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M. J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16763 Two cases of cutaneous eruptions due to COVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology Ho BWY, Wang D, Tan LYC, Bundele MM, Tan CH, Lim JH. J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16736 Concurrent chilblains and retinal vasculitis in a child with COVID-19 Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R. J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16801 Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V. J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16777 Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D’Incan M. J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16776 Dermoscopy features of COVID-19-related chilblains in children and adolescents Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A. J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16800 Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S. J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16775 COVID-19-related cutaneous manifestations associated with multiple drug sensitization Hayakawa J, Takakura H, Mizukawa Y, Shiohara T. J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16878 Acral skin eruption observed during SARS-CoV-2 pandemic: red palms and soles Neri I, Patrizi A, Gabrielli L, Virdi A, Veronesi G, Corsini I, Lazzarotto T, Lanari M, Misciali C, Guglielmo A. J Eur Acad Dermatol Venereol. 2020 Aug 20. doi: 10.1111/jdv.16881 Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine Abadías-Granado I, Palma-Ruiz AM, Cerro PA, Morales-Callaghan AM, Gómez-Mateo MC, Gilaberte Y, Schwartz RA. J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16903 Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding Kubanov AA, Deryabin DG. J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16902 A potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak Tai Y, Fukumoto T, Oka M, Nishigori C. J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16906 Chilblains and COVID-19: further evidence against a causal association M. Baeck, C. Peeters, A. Herman J Eur Acad Dermatol Venereol. 2020 Aug 31. doi.org/10.1111/jdv.16901 Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey Öksüm Solak E, Baran Ketencioglu B, Aslaner H, Çinar SL, Kartal D, Benli AR, Borlu M. J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16904 Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients Miot HA, Ianhez M, Ramos PM. J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17024 Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends Kluger N. J Eur Acad Dermatol Venereol. 2020 Oct 3 doi.org/10.1111/jdv.16974 SARS-CoV-2-induced telogen effluvium: a multicentric study O.M. Moreno‐Arrones A. Lobato‐Berezo A. Gomez‐Zubiaur S. Arias‐Santiago D. Saceda‐Corralo C. Bernardez‐Guerra R. Grimalt P. Fernandez‐Crehuet J. Ferrando R. Gil A. Hermosa‐Gelbard R. Rodrigues‐Barata D. Fernandez‐Nieto S. Merlos‐Navarro S. Vañó‐Galván J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17045 Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study D. Fernandez‐Nieto D. Ortega‐Quijano A. Suarez‐Valle J. Jimenez‐Cauhe P. Jaen‐Olasolo M. Fernandez‐Guarino J Eur Acad Dermatol Venereol. 2020 Dec 1 doi.org/10.1111/jdv.17051 Palmoplantar erythrodysesthesia: a diagnostic sign of COVID‐19 A. Nuno‐Gonzalez K. Magaletsky M. Feito Rodríguez A. Mayor Ibarguren M.J. Beato E. Ruiz Bravo P. Herranz Pinto J Eur Acad Dermatol Venereol. 2020 Dec 8 doi.org/10.1111/jdv.17074 Pityriasis rosea as a leading manifestation of COVID-19 infection R. Merhy, A.S. Sarkis, F. Stephan J Eur Acad Dermatol Venereol. 2020 Nov 30 doi.org/10.1111/jdv.17052 Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR M. F. García‐Gil J. Monte‐Serrano M. García García L. Prieto‐Torres A. J. Pascual‐del‐Riquelme I. Casas Flecha M. Ara‐Martín J Eur Acad Dermatol Venereol. 2021 Feb 4 doi.org/10.1111/jdv.17146 Chilblain-like lesions and COVID-19: second wave, second outbreak V. Piccolo A. Bassi T. Russo C. Mazzatenta M. Baraldi G. Argenziano I. Neri M. Cutrone J Eur Acad Dermatol Venereol. 2021 Feb 5 doi.org/10.1111/jdv.17145 Relapse of chilblain-like lesions during the second wave of COVID-19 S. Recalcati T. Barbagallo S. Tonolo M. Milani F. Fantini J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17168 Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals I. Neri F. Conti A. Virdi A. Guglielmo L. Leonardi I. Corsini C. Ghizzi L. Gabrielli T. Lazzarotto M. Lanari A. Patrizi C. Misciali J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17194 Association Between COVID-19 and Chilblains: A Case-Control Study D. Ortega‐Quijano D. Fernandez‐Nieto J. Jimenez‐Cauhe J.L. Cortes‐Cuevas D. Marcos‐Mencia M. Rodriguez‐Dominguez G. Segurado‐Miravalles M. Fernandez‐Guarino P. Jaen‐Olasolo J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17195 Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity A. García‐Irigoyen G.A. Acatitla‐Acevedo A. Barrera‐Godínez S. Méndez‐Flores J. Domínguez‐Cherit J Eur Acad Dermatol Venereol. 2021 Mar 17 doi.org/10.1111/jdv.17236 Periocular capillaritis in a COVID-19 positive patient: report of a case A. Paganelli F. Garbarino L. Bigi J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17227 Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? C Cassius  L Frumholtz  A de Masson  O Dadzie  A Petit  Saint‐Louis CORE (COvid Research) group J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17289 Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? S Signa  AR Sementa  MC Coccia  C Pastorino  G Viglizzo  S Viola  S Volpi  C Occella  D Bleidl  M Acquila  E Castagnola  A Ravelli  F Manunza J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17283 Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis A Polat Ekinci N Büyükbabani  S Meşe  G Pehlivan  NG Okumuş  A Ağaçfidan  E Özkaya J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17286 Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features D. Kadylak, W. Barańska-Rybak J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17424 Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology R. Guelimi, R. Salle, L. Dousset, H. Assier, S. Fourati, Z. Bhujoo, S. Barbarot, C. Boulard, C. Cazanave, A. Colin, E. Kostrzewa, C. Lesort, A. Levy Roy, F. Lombart, J. Marco Bonnet, L. Marty, J.B. Monfort, L. Riffaud, M. Samimi, M. Tardieu, E. Sbidian, P. Wolkenstein, L. Le Cleach, M. Beylot-Barry J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17322 Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19 Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu J Eur Acad Dermatol Venereol. 2021 May 13 doi/abs/10.1111/jdv.17347 Recurrent injection-site reactions after incorrect subcutaneous administration of the BNT162b2 vaccine against SARS-CoV-2 M. Gyldenløve, L. Skov, C.B. Hansen, P. Garred J Eur Acad Dermatol Venereol. 2021 May 12 oi/full/10.1111/jdv.17341 Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, Luc Sulimovic, Antoine Petit, Hervé Bachelez, Martine Bagot, Jean-David Bouaziz, Charles Cassius, Saint-Louis CORE (COvid REsearch) J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17393 Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17391 Development of eruptive pseudoangiomatosis following COVID-19 immunization – Apropos of 5 cases A. Mohta, S. K. Jain, R. D. Mehta, A. Arora J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17499 Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19) P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, N Samimi, M Amini, P Layegh J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17557 Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection M. Brito Caldeira, M. Pestana, A.L. João, C. Fernandes, A. João, N. Cunha J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17562 Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis V. Sánchez-García,R. Hernández-Quiles,E. de-Miguel-Balsa,A. Docampo-Simón,I. Belinchón-Romero,J.M. Ramos-Rincón J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17672 SARS-CoV-2 in the sweat of COVID-19-positive patients: a possible route of transmission? S. Recalcati,S. Tonolo,E. Meroni,F. Fantini J Eur Acad Dermatol Venereol. 2021 Aug 20 oi/full/10.1111/jdv.17607 Erythema annulare centrifugum triggered by SARS-CoV-2 infection N. Setó-Torrent,A. Altemir,M. Iglesias-Sancho,M.T. Fernández-Figueras J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17645 Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children I. Proietti,E. Tolino,A. Mambrin,N. Skroza,N. Bernardini,A. Marchesiello,F. Marraffa,S. Michelini,G. Rossi,S. Volpe,E. Del Giudice,R. Lubrano,C. Potenza J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17805 Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single center F. Diotallevi, S. Mazzanti, P. Properzi, S. Olivieri, A. Giacometti ,A. Offidani J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17803 COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases A. Tammaro, D. Karim, G.A.R. Adebanjo, F.R. Parisella, C. Chello, A.F. Salih, J. Rello J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17828 Pityrosporum folliculitis in critically ill COVID-19 patients F.L.X. Peres,R.R. Bonamigo,G.B. Bottega,F.L. Staub,A.S. Cartell,R.M. Bakos J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17842 Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle K. Hajra,U. Chakraborty,K. Chatterjee,A. Chandra,S. Halder J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17841 Eruptive pyogenic granulomas following COVID-19 C.A. Maronese, C. Moltrasio, D.A. Marletta, G. Genovese, A.V. Marzano J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17953 Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema A. Sechi, A. Bassi, C. Mazzatenta, M. Cutrone, L. Naldi, G. Argenziano, V. Piccolo J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18093 Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series A. Lepekhova, E. Grekova, O. Olisova, E. Dunaeva,S. Ali, I. Maximov, N. Teplyuk J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18118 A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms A. Aoki, M. Yamane, Y. Aoyama J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18119 Lessons from India’s COVID-19 crisis: Meyerozyma guillermondii presenting in a mucormycosis-like picture M. Shanshal J Eur Acad Dermatol Venereol. 2022 Apr 18 doi.org/10.1111/jdv.18159 Transient aquagenic syringeal acrokeratoderma during COVID-19 outbreak: a retrospective case series of eight patients P. Burgos-Blasco,M. González-Cañete,A. Melian-Olivera,D. Vega-Diez,I. Aldanondo-Fernandez de la Mora,B. Perez-Garcia,D. De Perosanz-Lobo J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18434 Authors’ reply to: ‘Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine’ Martina Bertello,Giovanni Rubegni,Pietro Rubegni,Linda Tognetti J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18486 Authors’ reply to comment by Ciccarese et al. regarding ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’ Esperanza Welsh,Jesus Alberto Cardenas-de la Garza,Elizabeth Brussolo-Marroquín,Adrian Cuellar-Barboza,Rodolfo Franco-Marquez,Gerardo Ramos-Montañez J Eur Acad Dermatol Venereol. 2022 August 20 doi.org/10.1111/jdv.18546 Comment on ‘Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions’ Giulia Ciccarese,Francesco Broccolo,Aurora Parodi,Francesco Drago J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18498 COVID-19 induced pityriasis rubra pilaris: A superantigenic disease? Italo Francesco Aromolo,Armando Pisapia,Davide Riva,Francesco Barberi,Angelo Valerio Marzano,Chiara Moltrasio,Maurizio Romagnuolo J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18556 New insights on acral peeling dermatoses: An overlooked skin manifestation during COVID-19 pandemic Iria Neri, Alba Guglielmo, Annalucia Virdi, Miriam Leuzzi, Bianca Maria Piraccini, Marco Adriano Chessa J Eur Acad Dermatol Venereol. 2022 December 14 doi.org/10.1111/jdv.18815 Dupilumab treatment for severe atopic dermatitis in children and SARS-CoV-2 infection: A combination of triggers for psoriasis Cristiana Colonna, Paolo Bortoluzzi, Riccardo Cavalli J Eur Acad Dermatol Venereol. 16 January 2023 doi.org/10.1111/jdv.18864 Study of covid-19 vaccine-related cutaneous adverse events following immunization and establishing a causal association Rohini Sharma J Eur Acad Dermatol Venereol. 20 January 2023 doi.org/10.1111/jdv.18891 COVID-19-associated chilblain pruritus is non-histaminergic mediated and correlated to epidermal interleukin 31 Angelina Labib, Leigh Nattkemper, Ashley Vander Does, Teresa Ju, Sara Cacciapuoti, Maria Vastarella, Gabriella Fabbrocini, Gil Yosipovitch J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18970    Telogen effluvium in SARS-CoV-2 infection: Histological aspects S. Michelini, G. Caro, M. Di Fraia, M. Fortuna, F. Magri, V. V. Gomes, T. Grieco, M. Carlesimo, A. Rossi, G. Pellacani J Eur Acad Dermatol Venereol. 08 March 2023  doi.org/10.1111/jdv.19015 Sweet syndrome following SARS-CoV-2 infection: A unique bullous photo-distributed presentation Cláudia Brazão, Dora Mancha, Luís Soares-de-Almeida, Paulo Filipe J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19038 Lingua villosa nigra in a child after COVID: Review and differential diagnosis with oral pigmentations of childhood Vincenzo Piccolo, Andrea Bassi, Ramon Grimalt, Carlo Mazzatenta, Giuseppe Argenziano, Andrea Sechi, Mario Cutrone J Eur Acad Dermatol Venereol. 27 March 2023  doi.org/10.1111/jdv.19070 Leprosy reactions after SARS-COV2 (COVID-19) infection I. M. Gutiérrez-Villarreal, J. Ocampo-Candiani, A. Villarreal-Martinez, M. Gomez-Flores, L. T. Fernández, G. Rodríguez-Tamez, D. M. Pérez-Garza, G. González-Martínez, L. A. Yamallel-Ortega, S. Chavez-Alvarez J Eur Acad Dermatol Venereol. 05 April 2023  doi.org/10.1111/jdv.19103 Acute generalized exanthematous pustulosis (AGEP) in a patient with COVID-19 infection De Brucker, Laura; Seyler, Lucie; Leemans, Gaelle; Gutermuth, Jan; Grosber, Martine J Eur Acad Dermatol Venereol. 15 April 2023 doi.org/10.1111/jdv.19119 A Case Of Eruptive Halo Nevi Following COVID-19 Ö. Gönüllü, F. Cebeci, T. Özen, M. S. Gürel, B. Ç. Şimşek J Eur Acad Dermatol Venereol. 04 May 2023 doi.org/10.1111/jdv.19157 On the characterization of the effluvium following COVID-19 infection A. C. Miola, P. M. Ramos, I. F. S. Mazeto, C. C. Brommonschenkel, H. A. Miot J Eur Acad Dermatol Venereol. 06 May 2023 doi.org/10.1111/jdv.19166 A case of Covid-19-related vulval ulceration coupled with genital viral shedding E. Mastoraki, S. Niforatou-Daskalaki, C. B. Bunker, G. Kravvas J Eur Acad Dermatol Venereol. 17 May 2023 doi.org/10.1111/jdv.19212 Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection S Skrek 1, V Di Lernia 2, A Beauchet 3, A-C Bursztejn 4, A Belloni Fortina 5, A Lesiak 6, J Thomas 7, P Brzezinski 8, Z Topkarci 9, N Murashkin 10, T Torres 11, R Epishev 10, A Chiriac 12, T McPherson 13, M Akinde 14, A Maruani 15, P C Luna 16, H Vidaurri de la Cruz 17, S Mallet 18, S Leducq 15, M Sergeant 4, J Zitouni 1, S K Mahil 19, C H Smith 14, C Flohr 13, H Bachelez 20 21, E Mahé 1; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology, and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.) J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19261 Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination” by Gambichler. Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Angelo Ruggiero J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19264 Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection Kazumasa Oya, Masakazu Kakurai, Kentaro Izumi, Norito Ishii, Toshifumi Nomura J Eur Acad Dermatol Venereol. 20 July 2023 doi.org/10.1111/jdv.19373 Lichen planus pemphigoides after COVID-19 infection D. Didona, Antonio M. Sequeira-Santos, J. Hinterseher, T. Cunha, M. Hertl J Eur Acad Dermatol Venereol. 04 Oct 2023 doi.org/10.1111/jdv.19542 Reactive infectious mucocutaneous eruption secondary to COVID-19 infection: A case report and review of the literature Georgia Koroneos, William Berry, Nicola Sweeney, Vanessa Morgan, Nur-Shirin Harun, Jenny Nicolopoulos J Eur Acad Dermatol Venereol. 31 Oct 2023 doi.org/10.1111/jdv.19590 Secondary livedoid vasculopathy following SARS-CoV-2 infection A. M. Carballido Vázquez, T. L. Vega López, P. Manchado López, G. Martínez García, A. Mateos Mayo J Eur Acad Dermatol Venereol. 14 December 2023 doi.org/10.1111/jdv.19729
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitisWollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411 European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactionsBalato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A. J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557 Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicKasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525 Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M. J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593 European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologicsJ.P. Thyssen C. Vestergaard S. Barbarot M.S. de Bruin‐Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.‐F. Stalder C. Gelmetti Z. Szalai Å. Svensson L.B. von Kobyletzki L. De Raeve R. Fölster‐Holst S. Christen‐Zaech D.J. Hijnen U. Gieler J. Gutermuth C. Bangert P.I. Spuls B. Kunz J. Ring A. Wollenberg M. Deleuran J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17167 Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicM. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, A.S. Payne, M.L. Yale, D. Zillikens, D.T. Woodley J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17207 Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, F. Meier, K. Peris, J. Olah, C. Posch J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17252
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? Di Altobrando A, Patrizi A, Bardazzi F. J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor Messina F, Piaserico S. J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16468 Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S. J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527 No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area – Bergamo, Lombardy, Italy Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P. J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552 “Toxic Erythema” and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 Patient Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16620 Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs Conti A, Lasagni C, Bigi L, Pellacani G. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16587 Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patient Benhadou F, Del Marmol V. J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16590 SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab Caroppo F, Biolo G, Belloni Fortina A. J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619 SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitorBalestri R, Rech G, Girardelli CR J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16571 Prior treatment with immunosuppressants among COVID-19 inpatients in one hospital in SpainPastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E J Eur Acad Dermatol Venereol. 2020 Jun 28. doi.org/10.1111/jdv.16798 Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso J Eur Acad Dermatol Venereol. 2020 Jun 21. doi: 10.1111/jdv.16761 Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech RepublicRob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J. J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16771 Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “Killing 2 birds with one stone”Saha M, D’Cruz A, Paul N, Healy R, Collins D, Charles DA, Sahu S, Fonia A. J Eur Acad Dermatol Venereol. 2020 Aug 17. doi: 10.1111/jdv.16887 Position Statement for a Pragmatic Approach to Immunotherapeutics in Patients with Inflammatory Skin Diseases during the COVID-19 Pandemic and BeyondJ. Beecker K.A. Papp J. Dutz R.B. Vender R. Gniadecki C. Cooper P. Gisondi M. Gooderham C.H. Hong M.G. Kirchhof C.W. Lynde C. Maari Y. Poulin L. Puig J Eur Acad Dermatol Venereol. 2021 Feb 3 doi.org/10.1111/jdv.17075 Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic K. Pandher C.L. Porter H.S. Patel W.W. Huang S.R. Feldman J Eur Acad Dermatol Venereol. 2020 Nov 17 doi.org/10.1111/jdv.17091 Good tolerance of hyaluronic acid injections during the Covid-19 pandemic period: a prospective observational real-life study of a cohort of 1093 patients with a 3 month-follow up periodMichael Naouri Serge Dahan Anne Le Pillouer Prost Phrynée Coutant‐Foulc Catherine Raimbault Françoise Cucurella Laurence Beille Muriel Creusot Martine Baspeyras Martine Darchy Randa Khallouf Hugues Cartier Isabelle Baratte Magali Dubois Olivier Cogrel Hans Laubach Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC) J Eur Acad Dermatol Venereol. 2021 Apr 8 doi.org/10.1111/jdv.17271 Autoantibodies in Covid19 – A model for viral induced autoimmunityJ. Berger, S. Volc J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17396 SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red ZoneSyed M. A. Ahmed,Martina Volontè,Eugenio Isoletta,Camilla Vassallo,Carlo Francesco Tomasini,Daniele Lilleri,Paola Zelini,Valeria Musella,Catherine Klersy,Valeria Brazzelli J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17721

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals
Kluger N.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690

SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?
Rongioletti F.
J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.
J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.

Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956

SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells
T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic

Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection
A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381

SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations
B Cribier, C Taieb, M Saint Aroman, J Shourick
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group
J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450

Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak
E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640

Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting
C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri
J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970

Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study

T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062

Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium
I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690

A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases

N. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal
J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738

Reply to ‘Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study’. by Bawane J et al

L. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720

Face mask-induced purpura: another unexpected effect of COVID era

V. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392

Effects of COVID-19 pandemic on malignant melanoma diagnosis

Alessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545

Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us

Juliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547

5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia

J. McCoy F.A. Cadegiani C.G. Wambier S. Herrera S. Vaño‐Galván N.A. Mesinkovska P.M. Ramos J. Shapiro R. Sinclair A. Tosti A. Goren
J Eur Acad Dermatol Venereol. 2020 Nov 2 doi.org/10.1111/jdv.17021

Extraordinary claims without extraordinary evidence Controversy on Anti-Androgen Therapy for COVID-19

R.M. Trüeb A. Régnier N. Caballero‐Uribe M.F. Reis Gavazzoni Dias H. Dutra Rezende
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17249

Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India

Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
J Eur Acad Dermatol Venereol. 2021 Jul 23 com/doi/10.1111/jdv.17532

Late-onset pustular skin eruption in a healthy neonate born from COVID-positive mother: a coincidence or a new skin sign of the infection?

V. Piccolo, C. Mazzatenta, T. Russo, F. Morandi, A. Bassi, G. Argenziano, E. Valerio, R. Grimalt, M. Cutrone
J Eur Acad Dermatol Venereol. 2021 Aug 7 doi/abs/10.1111/jdv.17579

Aquagenic Keratoderma as a consequence of excessive handwashing during the COVID-19 Pandemic – A Case Report

Raquel Falcão de Freitas, António Freitas

J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19459

Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination T. Gambichler L. Scholl L. Ocker R. Stranzenbach J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17225 Lichen planus arising after COVID-19 vaccination I. Hiltun J. Sarriugarte I. Martínez‐de‐Espronceda A. Garcés C. Llanos R. Vives J.I. Yanguas J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17221 Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine M. Ackerman D. Henry A. Finon R. Binois E. Esteve J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17248 Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization D. Fernandez‐Nieto J. Hammerle M. Fernandez‐Escribano CM Moreno‐del Real P. Garcia‐Abellas I. Carretero‐Barrio E. Solano‐Solares B de‐la‐Hoz‐Caballer J. Jimenez‐Cauhe D. Ortega‐Quijano M. Fernandez‐Guarino J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17250 Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report E. Akdaş N. İlter B. Öğüt Ö. Erdem J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17316 BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17320 Anaphylaxis to vaccination and polyethylene glycol (PEG): A perspective from the European Anaphylaxis Registry M Kraft, JM Renaudin, LF Ensina, A Kleinheinz, MB Bilò, K Scherer Hofmeier, S Dölle-Bierke, M Worm J Eur Acad Dermatol Venereol. 2021 Apr 29 doi/abs/10.1111/jdv.17327 Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek J Eur Acad Dermatol Venereol. 2021 May 22 doi/abs/10.1111/jdv.17343 Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen J Eur Acad Dermatol Venereol. 2021 May 13 com/doi/10.1111/jdv.17342 Purpuric lesions on the eyelids developed after BNT162b2 mRNA Covid-19 Vaccine: another piece of SARS-CoV-2 skin puzzle? C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi J Eur Acad Dermatol Venereol. 2021 May 28 oi/full/10.1111/jdv.17340 Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine I. Tessas, N. Kluger J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17422 SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17390 Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine P. K. Krajewski, J. C. Szepietowski J Eur Acad Dermatol Venereol. 2021 Jun 2 com/doi/10.1111/jdv.17444 Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 C. Lesort, J. Kanitakis, L. Donzier, D. Jullien J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17451 Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccineO.M. Orenay, I. Balta, D. Yigit, M. Eksioglu J Eur Acad Dermatol Venereol. 2021 Jun 17 oi/10.1111/jdv.17454?af=R Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccineP.K. Krajewski, Ł. Matusiak, J.C. Szepietowski J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17449 First dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose contraindicated?G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17472 Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?J.E. Kim, H. Lee, S.S. Paik, J.-Y. Moon, H.J. Yoon, S.-H. Kim J Eur Acad Dermatol Venereol. 2021 Jun 24 com/doi/10.1111/jdv.17476 Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2F. Solimani, Y. Mansour, D. Didona, A. Dilling, K. Ghoreschi, K. Meier J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17480 Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccineN. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17500 Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccinationA. Kreuter, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17514 Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccineD. Falkenhain-López, C. Gutiérrez-Collar, J. Arroyo-Andrés, I. Gallego-Gutiérrez, J.L. Rodríguez-Peralto, A. Sánchez-Velázquez J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17497 ‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccineW. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17506 Erythema multiforme after CoronaVac vaccinationN.T. Lopes, C.E.O. Pinilla, A.C. Gerbase J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17495 New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination L. Quattrini, L. Verardi, G. Caldarola, G. Peluso, C. De Simone, M. D’Agostino J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17502 Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine A.C. Leasure, S.E. Cowper, J. McNiff, J.M. Cohen J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17494 New-onset cutaneous lichen planus triggered by COVID-19 vaccinationR. Merhy, A.-S. Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan J Eur Acad Dermatol Venereol. 2021 Jul 8 oi/full/10.1111/jdv.17504 Pityriasis rosea developing after COVID-19  vaccinationO.Y. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17498 Herpes Zoster following SARS-CoV-2 vaccination – a series of four casesM. Alpalhão, P. Filipe J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17555 Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2L. Guzmán-Pérez, M. Puerta-Peña, D. Falkenhain-López, J. Montero-Menárguez, C. Gutiérrez-Collar, J.L. Rodríguez-Peralto, J. Sanz-Bueno J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17547 New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three casesD. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17553 Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccineF. Nastro, G. Fabbrocini, F. di Vico, C. Marasca J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17550 Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccineA. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller J Eur Acad Dermatol Venereol. 2021 Jul 26 doi/abs/10.1111/jdv.17549 New onset of mainly guttate psoriasis after COVID-19 vaccination: a case reportM. Lehmann, P. Schorno, R.E. Hunger, K. Heidemeyer, L. Feldmeyer, N. Yawalkar J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17561 A skin reaction with rust-like discolouration to mRNA COVID-19 vaccineR. Pasternack, S. Pohjavaara J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17543 Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17542 Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the PhilippinesJ.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17575 Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case seriesM. Vastarella, V. Picone, F. Martora, G. Fabbrocini J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17576 Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)L. Juay, N.S. Chandran J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17581 Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centreE. Akdaş, B. Öğüt, Ö. Erdem, M.O. Öztaş, N. İlter J Eur Acad Dermatol Venereol. 2021 Aug 9 oi/full/10.1111/jdv.17592 Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureE. Annabi,N. Dupin,P. Sohier,B. Garel,N. Franck,S. Aractingi,S. Guégan,B. Oulès J Eur Acad Dermatol Venereol. 2021 Aug 7 doi.org/10.1111/jdv.17578 Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults A.K. Özdemir, S. Kayhan, S.K. Çakmak J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17577 Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centreE. Sotiriou, A. Tsentemeidou, K. Bakirtzi, A. Lallas, D. Ioannides, E. Vakirlis J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17582 Erythema gyratum repens after COVID-19R. Castro Silva, G. Castro Silva, M.C. Castro Silva, O. Lupi J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17583 A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccinationA. D’Cruz,H. Parker,M. Saha J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17606 Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinationsG. Ciccarese,F. Drago,A. Rebora,A. Parodi J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17615 ‘COVID vaccine arm’ may present after both mRNA vaccines vaccinationS. Gregoriou,I. A. Kleidona,A. Tsimpidakis,E. Nicolaidou,A. Stratigos,D. Rigopoulos J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17614 Flagellate purpura associated with COVID-19 vaccinationE. Heck,B.D. Rankin,M. Schneider,V.H. Prajapati J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17609 Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccinesM. Tihy,S. Menzinger,R. André,E. Laffitte,L. Toutous-Trellu,G. Kaya J Eur Acad Dermatol Venereol. 2021 Aug 30 com/doi/10.1111/jdv.17633 Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccineL. Huang, Z. Yao, J. Zhang J Eur Acad Dermatol Venereol. 2021 Sep 7 oi/full/10.1111/jdv.17648 Varicella Zoster and Herpes Simplex Virus Reactivation Post-COVID-19 Vaccination: A Review of 40 Cases in an International Dermatology RegistryRamie A. Fathy,Devon E. McMahon,Cynthia Lee,Grace C. Chamberlin,Misha Rosenbach,Jules B. Lipoff,Anisha Tyagi,Seemal R. Desai,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Marlys Fassett,Lindy P. Fox,Harry L. Greenberg,Kimberly Blumenthal,Esther E. Freeman J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17646 COVID vaccine-induced lichen planus on areas previously affected by vitiligoVincenzo Piccolo,Carlo Mazzatenta,Andrea Bassi,Giuseppe Argenziano,Mario Cutrone,Ramon Grimalt,Teresa Russo J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17687 Erythema multiforme after SARS-CoV-2 vaccineLi-wen Zhang,Wen-ju Wang,Cong-hui Li,Tao Chen J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17689 New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?David Pesqué,Emilio Lopez-Trujillo,Orianna Marcantonio,Ana Maria Giménez-Arnau,Ramon Maria Pujol J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17690 Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccineLaurence de Montjoye,Liliane Marot,Marie Baeck J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17685 Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema MultiformeLuca Borg,Liam Mercieca,Dillon Mintoff,Daniel Micallef,David Pisani,Alexandra Betts,Lawrence Scerri J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17682 Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID-19 vaccine: report of three cases from IndiaHitaishi Mehta,Sanjeev Handa,Pankaj Malhotra,Meenakshi Patial,Smriti Gupta,Anirudh Mukherjee,Debajyoti Chatterjee,Aastha Takkar,Rahul Mahajan J Eur Acad Dermatol Venereol. 2021 Sep 21 doi/abs/10.1111/jdv.17678 Early atypical injection-site reactions to COVID-19 vaccine: a case seriesM. Vaccaro,L. Bertino,R. Squeri,C. Genovese,S. Isola,G. Spatari,E. Spina,P. Cutroneo J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17683 Nevocentric erythema multiforme after SARS-COV-2 VaccineC. Scharf,E. V. di Brizzi,S. Pellerone,M. Liguori,C.M.R. Giorgio,G. Argenziano J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17688 SARS-CoV-2 mRNA Vaccine Injection Site PseudolymphomaDillon Mintoff,Lawrence Scerri,Alexandra Betts J Eur Acad Dermatol Venereol. 2021 Sep 21 oi/10.1111/jdv.17680?af=R A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccineJ. Young,L. Mercieca,M. Ceci,D. Pisani,A. Betts,M.J. Boffa J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17676 Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccinationE Panou,V Nikolaou,L Marinos,S Kallambou,P Sidiropoulou,M Gerochristou,A Stratigos J Eur Acad Dermatol Venereol. 2021 Oct 10 doi.org/10.1111/jdv.17736 Development of oral lichen planus after COVID-19 vaccination – a rare case reportP. Sharda, A. Mohta, B.C. Ghiya, R.D. Mehta J Eur Acad Dermatol Venereol. 2021 Oct 4 oi/full/10.1111/jdv.17718 Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer)Corrado Zengarini,Cosimo Misciali,Tiziana Lazzarotto,Emi Dika J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17723 Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacyV. Schmidt,R. Blum,M. Möhrenschlager J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17722 Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case seriesD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A. Katoulis,V. Koumaki,G. Evangelou,M. Stefanidou,D. Mylonakis,K. Zografaki,K. Krasagakis J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17720 Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence S.G. Brooks,R. Alhusayen,V. Piguet,D. Croitoru J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17719 Cutaneous findings following COVID-19 vaccination: Review of world literature and own experienceThilo Gambichler,Stefanie Boms,Laura Susok,Heinrich Dickel,Cansu Finis,Nessr Abu Rached,Milan Barras,Markus Stücker,Dimitri Kasakovski J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17744 Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?Cristina Moya-Martinez,Emilio de Dios Berná-Rico,Ana Melian-Olivera,Carmen Moreno-Garcia del Real,Diego Fernández-Nieto J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17750 Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)Minjae Kim,Jee Woo Kim,Minsu Kim,Sun Young Choi,Jung-Im Na J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17757 Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanomaManon Blaise,Fanny Rocher,Hélène Spittler,Adrien Sanchez,Elisabeth Lanteri,Lucia Coco,Angela Puma,Arnaud Martel,Geraldine Gonfrier,Thierry Passeron,Henri Montaudié J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17760 Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workersPawinee Rerknimitr,Thanaporn Puaratanaarunkon,Chanidapa Wongtada,Namthong Wittayabusarakam,Saran Krithin,Leilani Paitoonpong,Chanat Kumtornrut,Stephen J Kerr,Pravit Asawanonda,Watsamon Jantarabenjakul,Jettanong Klaewsongkram J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17761 Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccineNorma Cameli,Martina Silvestri,Maria Mariano,Luigi Bennardo,Steven Paul Nisticò,Antonio Cristaudo J Eur Acad Dermatol Venereol. 2021 Oct 18 com/doi/10.1111/jdv.17762 Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine C Kouki,K Sellami,E Bahloul,M Amouri,A Masmoudi,H Turki J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17751 Regression of common viral warts after ChAdOx1-S COVID-19 vaccineAnna Płaszczyńska,Martyna Sławińska,Michał Sobjanek J Eur Acad Dermatol Venereol. 2021 Oct 26 doi.org/10.1111/jdv.17771 Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruptionA. Sernicola,A. Dybala,V. Gomes,P. Maddalena,F. Adotti,G. Soda,R. Muharremi,P. Fino,E. Del Duca,T. Grieco J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17807 Eosinophilic dermatosis after AstraZeneca COVID-19 vaccinationE. Cinotti,J.-L. Perrot,F. Bruzziches,L. Tognetti,A. Batsikosta,E. Sorrentino,A.V. Marzano,P. Rubegni J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17806 Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al E. Camela,G. Guerrasio,C. Patruno,M. Scalvenzi,N. Di Caprio,G. Fabbrocini,M. Napolitano J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17866 Emergence of Behçet’s disease post-SARS-CoV2-vaccination: two clinical cases in JapanH. Hashizume,S. Ajima,Y. Ishikawa J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17859 Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patientG.V. Knechtl,S.M. Seyed Jafari,T. Berger,A. Rammlmair,L. Feldmeyer,L. Borradori J Eur Acad Dermatol Venereol. 2021 Dec 12 doi.org/10.1111/jdv.17868 Exuberant lichenoid eruption after Oxford–AstraZeneca COVID-19 vaccine: a singular caseC. Correia,S. Fernandes,L. Soares-de-Almeida,P. Filipe J Eur Acad Dermatol Venereol. 2021 Dec 16 doi.org/10.1111/jdv.17872 Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)C. Masseran,A. Calugareanu,F. Caux,G. Bohelay J Eur Acad Dermatol Venereol. 2021 Dec 21 doi.org/10.1111/jdv.17899 Lichen planus after CoronaVac: a rare complication of vaccines A. Satılmış Kaya,N. Cemşitoğlu,E. Adışen,Ö. Erdem J Eur Acad Dermatol Venereol. 2022 Jan 6 doi.org/10.1111/jdv.17906 Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature reviewM. Pauluzzi,G. Stinco,E. Errichetti J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17891 Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohortE. Massip,P. Marcant,G. Font,S. Faiz,S. Duvert-Lehembre,I. Alcaraz,A. Vermersch-Langlin,M. Véron,C. Macaire,K. Faure,F. Vuotto,D. Staumont-Sallé,F. Dezoteux J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17883 SCLE manifestation after mRNA COVID-19 vaccinationL. Rechtien,C. Erfurt-Berge,M. Sticherling J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17895 Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccinationA. Kuzumi,A. Yoshizaki,K. Chiba,S. Mitsuo,K.M. Matsuda,Y. Norimatsu,K. Nagai,J. Omatsu,T. Miyake,S. Sato J Eur Acad Dermatol Venereol. 2021 Nov 28 doi.org/10.1111/jdv.17837 Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiaeA.L. Tatu,T. Nadasdy,L.C. Nwabudike J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17864 Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccineJ. Kaikati,A. Ghanem,R. El Bahtimi,J. Helou,R. Tomb J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17920 COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasisV. Piccolo,T. Russo,C. Mazzatenta,A. Bassi,G. Argenziano,M. Cutrone,M. E. S. Danielsson Darlington,R. Grimalt J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17918 COVID vaccine-induced reaction around molluscum contagiosum with secondary partial clearance of lesions V. Piccolo,A. Bassi,C. Mazzatenta,G. Argenziano,M. Cutrone,R. Grimalt,T. Russo J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17919 Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccineC. Aimo,E.B. Mariotti,A. Corrà,E. Cipollini,O. Le Rose,C. Serravalle,N. Pimpinelli,M. Caproni J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17988 Pityriasis Lichenoides et Varioliformis Acuta Following COVID-19 mRNA VaccinationJ. Palmén,M. Lepistö,L. Talve,N. Hieta J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17912 Cutaneous Reactions due to Pfizer’s BNT162b2 mRNA and Moderna’s mRNA-1273 VaccinesA. Oulee,S. Salem,R. Yahia,K. Yang,D. Garcia,A. Holmes,B. Furukawa J Eur Acad Dermatol Venereol. 2022 Jan 13 doi.org/10.1111/jdv.17925 Wells’ syndrome following Oxford–AstraZeneca COVID-19 vaccinationY. H. Kim,Y. C. Kim J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17916 Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination A.K. Panda,F. Begum,M. Panda,A.K. Jena J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17915 Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centreD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A.C. Katoulis,I. Gkiaouraki,K. Zografaki,D. Mylonakis,K. Krasagakis J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17965 Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al.G. Avallone,S. Giordano,C. Astrua,M. Merli,R. Senetta,C. Conforti,S. Ribero,A.V. Marzano,P. Quaglino J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17959 A first case of “Covid toes” from a viral vector-based COVID-19 vaccineA. Van Loon,D. Mortelmans,V. Siozopoulou,B. Ogunjimi,H. Jansens,J. Lambert,O. Aerts J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17948 Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccinationT. Ogawa,U. Aitake,T. Nomura J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17947 A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from IndiaP. Das,S. Arora,G.K. Singh,P. Bellad,R. Rahman,A. Bahuguna,D. Sapra,R. Shrivastav,A. Gupta J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17951 Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccinationW.-K. Hung,C.-C. Chi J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17955 “COVID nose” – a unique post-COVID pigmentary sequelae reminiscing Chik sign: a descriptive case seriesA. Sil,A. Panigrahi,A. Chandra,J.D. Pramanik J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17989 Reply to “COVID vaccine-induced lichen planus on areas previously affected by vitiligo”E. Bularca,J. Monte-Serrano,P. Villagrasa-Boli,A. Lapeña-Casado,S. de-la-Fuente J Eur Acad Dermatol Venereol. 2022 Feb 11 doi.org/10.1111/jdv.18001 Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adultT. Prarthana,S. Bakshi,V. Hanumanthu,U. Nahar,D. De J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17990 Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitisC. Zengarini,A. Pileri,F.P. Salamone,B.M. Piraccini,G. Vitale,M. La Placa J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17827 Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the kneesA. Bassi,C. Mazzatenta,A. Sechi,M. Cutrone,V. Piccolo J Eur Acad Dermatol Venereol. 2022 Feb 21 doi.org/10.1111/jdv.18025 A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccineS. Ohmura,S. Hanai,R. Ishihara,Y. Ohkubo,T. Miyamoto J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18013 Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopeniaY.-T. Hung,Y.-L. Huang,Y.-Y. Chang,W.-T. Chen J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18014 Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccinationT. Mäkilä,L. Jeskanen,M. Butina,L. Harjama,A. Ranki,T. Mälkönen,N. Kluger J Eur Acad Dermatol Venereol. 2022 Feb 19 doi.org/10.1111/jdv.18024 Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumabG. Pavia,L. Gargiulo,F. Spinelli,J. Avagliano,M. Valenti,R. G. Borroni,A. Costanzo,A. Narcisi J Eur Acad Dermatol Venereol. 2022 Feb 27 doi.org/10.1111/jdv.18032 Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19M. Kasperkiewicz,D.T. Woodley J Eur Acad Dermatol Venereol. 2022 Feb 26 doi.org/10.1111/jdv.18030 Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemicT. Fachler,K. Olshtain-Pops,L. Horev J Eur Acad Dermatol Venereol. 2022 Feb 28 doi.org/10.1111/jdv.18035 Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoinP.R. Criado,M. Ianhez,P.S. Rocha,H.A. Miot J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18055 Erythema gyratum repens after COVID vaccinationD. Chiquito,J.C.C. Xavier-Junior,G. Peres,O. Lupi J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18061 Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)C. Ben Salem,A. Khelif,D. Sahnoun,N. Ghariani,B. Sriha,M. Denguezli J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18059 Case of lichen planus pigmentosus–inversus after Oxford–AstraZeneca COVID-19 vaccine: cause or coincidence?L. Sun,S. Duarte,L. Soares-de-Almeida J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18058 Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination  A. Yoshida,T. Ikegami,K. Igawa J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18060 Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomesF. Etaee,M. Eftekharian,T. Naguib,S. Daveluy J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18063 Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine I. Lahouel,N. Ben Salah,N. Ben Fadhel,F. Chahed,N. Ouni,H. Belhadjali,K. Aouem,J. Zili J Eur Acad Dermatol Venereol. 2022 Mar 28 doi.org/10.1111/jdv.18108 Transient inflammation in surgical scars following Covid-19 mRNA vaccinationC. Ferreli,J. Anedda,L. Atzori J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18088 De novo annular pustular psoriasis following mRNA COVID-19 vaccineM. Romagnuolo,P. Pontini,S. Muratori,A. V. Marzano,C. Moltrasio J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18114 Commentary on ‘Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine’D. Turkmen,N. Altunisik J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18117 Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from BrazilC.A. Seque,M.M.S.S. Enokihara,M.M. Nascimento,A.M. Porro,J. Tomimori J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18112 Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccinationY.-T. Hung,W.-H. Chung,T.-F. Tsai,C.-B. Chen J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18132 Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccinationM. Mizutani,H. Mitsui,T. Amano,Y. Ogawa,N. Deguchi,S. Shimada,A. Miwa,T. Kawamura,Y. Ogido J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18136 SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruptionD. Mintoff,D. Pisani,N. Livori,I. Said-Huntingford,G. Baldacchino J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18149 Cutaneous adverse effects of the available COVID-19 vaccines in India: a questionnaire-based studyJ. Bawane,R. Kataria,A. Mohite,K. Verma,U. Shukla J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18150 Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine N. Ben Salah,M. Korbi,N. Ben Fadhel,I. Safa,F. Chad,M. Njima,H. Belhadjali,M. Amri,K. Aouam,J. Zili J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.18336 Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose M.S. Roth,S. Chantraine,C.A. Morales Mateluna,K. Hartmann,C.T. Berger J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18387 Generalized and persistent skin pigmentation after COVID-19 vaccination J. Lu,Y. Liu,Y. Sun J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18379 Influence of Covid-19 vaccination on immune-mediated skin diseases N. A. Alelq,M. E. Kubieniec,L. E French,J. C. Prinz J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18388 Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccineJ. Franceschi,A.S. Darrigade,P. Sanchez-Pena,V. Legrain-Lifermann,B. Milpied J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18389 Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine F. Drago,G. Ciccarese,A. Guadagno,A. Parodi J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18418 A severe case of papulovesicular exthanthema with rhabdomyolysis after corona virus disease 2019 heterologous booster vaccination A. Baba,Y. Maki,T. Kanekura,H. Tsubouchi J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18420 Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to ‘Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review’ by Pauluzzi et al. Fabrizio Martora,Angelo Ruggiero,Teresa Battista,Gabriella Fabbrocini,Matteo Megna J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18503 Alopecia areata after COVID-19 infection and vaccination: A cross-sectional analysis Betty Nguyen,Antonella Tosti J Eur Acad Dermatol Venereol. 2022 August 11 doi.org/10.1111/jdv.18491 New-onset vitiligo after COVID-19 mRNA vaccination: A causal association? Electra Nicolaidou,Charitomeni Vavouli,Ioannis-Alexios Koumprentziotis,Maria Gerochristou,Alexander Stratigos J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18513 Association of interstitial granulomatous dermatitis with messenger Rna–1273 Sars-Cov-2 vaccine Cesare Ariasi,Gabriele Perazzolli,Alessandra Gelmetti,Simonetta Battocchio,Piergiacomo Calzavara-Pinton J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18490 New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination Mina Almasi-Nasrabadi,Radha S. Ayyalaraju,Ashish Sharma,Somaia Elsheikh,Shanti Ayob J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18484 Skin reaction after SARS-CoV-2 vaccines Reply to ‘cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience’ Fabrizio Martora,Alessia Villani,Claudio Marasca,Gabriella Fabbrocini,Luca Potestio J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18531 Reply to ‘Nail psoriasis: A rare mRNA COVID-19 vaccine reaction’ by Lamberti A et al. Angelo Ruggiero,Luca Potestio,Teresa Battista,Gabriella Fabbrocini,Matteo Megna J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18537 Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals Gianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, Cesare Massone, Luca Mastorino, Andrea Paradisi, Alessandro Pileri, Pietro Quaglino, Nathalie Rizzo, Simone Ribero, Gabriele Roccuzzo, Gianluca Tavoletti, Carlo Alberto Vignoli, Iris Zalaudek, Emilio Berti, Silvia Alberti-Violetti J Eur Acad Dermatol Venereol. 2022 December 05 doi.org/10.1111/jdv.18806 Epidermal necrolysis after COVID−19 vaccination: An exploratory analysis using World Health Organization VigiBase Btisseme Ahouach, Emmanuelle Diaz, Blandine Bertin, Benoit Ben Said, Sandrine Combret, Aurélie Grandvuillemin, Nadine Petitpain, Marie Blanche Rabier, Laure Thomas, Thierry Trenque, Saskia Ingen-Housz-Oro, Bénédicte Lebrun-Vignes J Eur Acad Dermatol Venereol. 2023 January 06 doi.org/10.1111/jdv.18845 Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al. L. Sun, C. Brazão, D. Mancha, L. Soares-de-Almeida, P. Filipe J Eur Acad Dermatol Venereol. 22 January 2023 doi.org/10.1111/jdv.18893 Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study C. Seree-aphinan, P. Suchonwanit, P. Rattanakaemakorn, C. Pomsoong, Y. Ratanapokasatit, C. Setthaudom, T. Suangtamai, K. Chanprapaph, the COVIDVAC-DERM study group J Eur Acad Dermatol Venereol. 20 January 2023 doi.org/10.1111/jdv.18890 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid F. Solimani, A. Mesas-Fernández, E. Bodner, M. Carevic-Neri, M. Hasheminasab, T. Jakovljevicova, A. Philipp, A. Nast, M. Worm, F. J. Hilke, K. Meier, K. Ghoreschi J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18967 Increasing the COVID-19 immunization rate through allergy testing R. K. Bent, J. Weinbrenner, V. Faihs, S. Steffens, T. Nau, M. Vitus, S. Mathes, U. Darsow, T. Biedermann, K. Brockow J Eur Acad Dermatol Venereol. 18 February 2023 doi.org/10.1111/jdv.18979 Generalized painful papulovesicular eruption following the COVID-19 BNT162b2 mRNA vaccine J. M. Lee, Y. S. Lee, Y. J. Lee, J. H. Lee, T. Y. Han, J. E. Choi J Eur Acad Dermatol Venereol. 13 March 2023  doi.org/10.1111/jdv.19043 Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Case Possibly Induced by COVID-19 Vaccine Hülya Cenk, Mahmut Anıl Karataş, Niyazi Çetin, Erdem Çomut, Şule Gökşin, Özge Sevil Karstarlı Bakay, Nida Kaçar J Eur Acad Dermatol Venereol. 28 March 2023  doi.org/10.1111/jdv.19065 Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: first report Corrado Zengarini, Vito Epifani, Carlotta Baraldi, Martina Mussi, Luciano Potena, Laura Giovannini, Alessandro Pileri J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19099 VEXAS syndrome following COVID-19 mRNA vaccination François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, Suzann Pechuzal, Jean-Luc Perrot J Eur Acad Dermatol Venereol.  05 April 2023  doi.org/10.1111/jdv.19104 A case of erythema elevatum diutinum after COVID-19 vaccination Bushra Muna J Eur Acad Dermatol Venereol. 12 May 2023  doi.org/10.1111/jdv.19188 A case of recurrence of pyoderma gangrenosum after Covid-19 vaccine L. Bettolini, S. Bighetti, S. Mezzana, A. Gelmetti, P. Calzavara-Pinton, V. Maione J Eur Acad Dermatol Venereol. 20 June 2023 doi.org/10.1111/jdv.19285 New-onset pemphigus vulgaris and pemphigus foliaceus following COVID-19 infection and vaccination, systematic review of case reports and a causal hypothesis S. Petti, P. G. Arduino J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19271 Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS-CoV-2 vaccine – a case review K. Kanabaj, M. Sokołowska-Wojdyło, A. Wilkowska, R. J. Nowicki J Eur Acad Dermatol Venereol. 06 July 2023 doi.org/10.1111/jdv.19305 Ulcerating Reaction in Association with Pfizer-BioNTech COVID-19 Vaccine in an 11-Year-Old Boy Justin Thrush, Samantha Polly, John Anthony, James Fernandez, James Taylor, DeVon C. Preston, Anthony P. Fernandez J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19460 A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA Raquel Falcão de Freitas, António Freitas J Eur Acad Dermatol Venereol. 18 August 2023 doi.org/10.1111/jdv.19444 A case of generalized pustular psoriasis complicated by acute respiratory distress syndrome after COVID-19 vaccination Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, Akihiro Horie, Tatsuro Okano, Sora Takeuchi, Takayasu Ando, Takafumi Kadono J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19401 A severe relapse of Pemphigus Vulgaris after SARS-CoV-2 vaccination. L. Ligrone, S. Lembo, F. Cillo, S. Spennato, G. Fabbrocini, A. Raimondo J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19414 Annular cutaneous sarcoidosis following COVID-19 vaccination José Ramos, António Silva, Ângela Roda, João Alves J Eur Acad Dermatol Venereol. 01 February 2024 doi.org/10.1111/jdv.19828
Dermatology staff participate in fight against Covid-19 in ChinaZheng Y, Lai W J Eur Acad Dermatol Venereol. 2020 Mar 23. doi: 10.1111/jdv.16390 Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemicGheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16492 Covid-19: Countermeasure for N95 mask-induced pressure soreYin Z. J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16490 Hand disinfection in the combat against Covid-19Goldust M, Abdelmaksoud A, Navarini AA J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16574 COVID-19 epidemic: Skin protection for health care workers must not be ignoredZhang B, Zhai R, Ma L. J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16573 Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patientsPei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16570 Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemicCampbell V, Middleton D, Donnelly J, Hunter H J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16624 Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 casesSingh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A J Eur Acad Dermatol Venereol. 2020 May 12. doi: 10.1111/jdv.16628 Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled studyDong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16638 Protecting medical staff from skin injury/disease caused by personal protective equipments during epidemic period of COVID-19: experience from ChinaH. Long, H. Zhao, Z. Yao, B. Cheng, Q. Lu J Eur Acad Dermatol Venereol 2020; May 22 doi.org/10.1111/jdv.16388 Hand Eczema Pandemic Caused by COVID-19 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital PersonnelK. Greveling, A.C.M. Kunkeler J Eur Acad Dermatol Venereol 2020 June 2 doi.org/10.1111/jdv.16695 Retroauricular dermatitis with vehement use of ear loop face masks during COVID‐19 pandemicBothra A, Das S, Singh M, Pawar M, Maheswari A J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16692 Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United KingdomHadjieconomou S, Hughes J, Kamath S J Eur Acad Dermatol Venereol. 2020 Jun 14. doi: 10.1111/jdv.16754 Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I J Eur Acad Dermatol Venereol. 2020 Jun 15. doi: 10.1111/jdv.16755 How the use of surgical masks during COVID-19 pandemic can induce skin effectsVeronese S, Bernardi P, Sbarbati A J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16905 Occupational dermatoses from PPE during the COVID-19 pandemic in the tropics – A reviewLee HC, Goh CL J Eur Acad Dermatol Venereol. 2020 Sep 7. doi: 10.1111/jdv.16925 Adverse skin reactions following different types of mask usage during the COVID-19 pandemicC. Chaiyabutr T. Sukakul C. Pruksaeakanan J. Thumrongtharadol W. Boonchai J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17039 Adverse skin reactions related to PPE among health care workers managing Covid-19Priyanka Sharma Nainika Goel Kanika Dogar Mala Bhalla GP Thami Kavita Punia J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17290 Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in KoreaS.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, S.J. Seo, K.Y. Park J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17447 Dermatoses caused by face mask wearing during the COVID-19 pandemicO.Yu. Olisova, N.P. Teplyuk, E.V. Grekova, A.A. Lepekhova J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17546 Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19C. Huang, Q. Sun, D. Jiang, X. Zhang, C. Chen, D. Yan, X. Liu, Y. Zhou, C. Ding, L. Lan, J. Wu, L. Li, A. Li, X. Liu, S. Yang J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17580 Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type?S Cretu,M Dascalu,SR Georgescu,CM Salavastru J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17679 Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic”F. Bardazzi,L. Sacchelli,C. Loi,F. Filippi,A. Guglielmo J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18012 Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic L.F. Kiely,C. O’Connor,G. O’Briain,C. O’Briain,J. Gallagher,J.F. Bourke J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18054 Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer) C. Zengarini,C. Misciali,T. Ferrari,E. Dika,M. La Placa,B.M. Piraccini,C. Baraldi J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.16925

Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances

Reinholz M, French LE.
J Eur Acad Dermatol Venereol. 2020 Mar 27. doi: 10.1111/jdv.16391

Dermatologic Surgery Training During the COVID-19 Era

García-Lozano JA, Cuellar-Barboza A, Garza-Rodríguez V, Vázquez-Martínez O, Ocampo-Candiani JJ Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16621

Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions

E. Welsh,J.A. Cardenas-de la Garza,E. Brussolo-Marroquín,A. Cuellar-Barboza,R. Franco-Marquez,G. Ramos-Montañez
J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16391

Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination

A. Kreuter,S. Lausch,S.-N. Burmann,A. Paschos,A.-L. Michalowitz
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16621

Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies

Garcovich S, Bersani FS, Chiricozzi A, De Simone C
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16535

Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic

M. Kasperkiewicz,R. Strong,M. Yale,P. Dunn,D.T. Woodley
J Eur Acad Dermatol Venereol. 2022 Apr 25 doi.org/10.1111/jdv.16535

Impact of COVID-19 pandemic on acute dermatology referrals in a secondary and tertiary care Central London hospital. A retrospective comparison review of pre-COVID-19 era and COVID-19 pandemic

Evangelia Panagou, Evdoxia Panou, Jennifer Crawley, Ophelia Veraitch, Emma V. Edmonds, Chris B. Bunker, Claire L. Martyn-Simmons
J Eur Acad Dermatol Venereol. 24 February 2023 doi.org/10.1111/jdv.18997

The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres

Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F. Cheng, Mitchell L. Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou
J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18953

Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID-19 pandemic in a reference center in Mexico

Eduardo Corona-Rodarte, Antonio Olivas-Martinez, Rodrigo Solis-Pompa, Luis Enrique Cano-Aguilar, Daniel Asz-Sigall, María del Rocío Ferrusco-Ontiveros, José Alfredo Soto-Ortiz, Liliana Burgos-Mora
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19109

SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routesDelfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16591 Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practiceSacchelli L, Viviani F, Orioni G, Rucci P, Rosa S, Lanzoni A, Patrizi A, Gaspari V. J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16694 STIs and the COVID-19 pandemic: the lockdown does not stop sexual infectionsBalestri R, Magnano M, Rizzoli L, Infusino SD, Urbani F, Rech G J Eur Acad Dermatol Venereol. 2020 Jul 11. doi: 10.1111/jdv.16808 Evolution of notified sexual transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic G. Martin-Ezquerra, P. Monreal, L. Mercuriali, E. Cañas-Ruano, R.M. Pujol, X. Duran, M. Masferrer Niubò, P. Domingo, J. Villar-Garcia, J. Lopez-Contreras, A. Gonzalez-Cordón, P. Garcia-Olalla, M.-J. Barberá, STI-HIV group of Barcelona J Eur Acad Dermatol Venereol. 2021 Jun 19 oi/full/10.1111/jdv.17460 Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virusM. Hertel,M. Heiland,S. Nahles,M. von Laffert,C. Mura,P.E. Bourne,R. Preissner,S. Preissner J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16591 Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workersX. Lin,Y.Z. Li,T. Chen,S.H. Min,D.F. Wang,M.M. Ding,G. Jiang J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16694 Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany – a nationwide analysisJ. Kleemann,M. Meissner,D. Özistanbullu,Ü. Balaban,O. Old,S. Kippenberger,J. Kloka,R. Kaufmann,K. Zacharowski,B. Friedrichson J Eur Acad Dermatol Venereol. 2022 May 15 doi.org/10.1111/jdv.16808 Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIVAgit Simsek, Clara Bessen, Toni L Meister, Doris Urlaub, Adriane Skaletz-Rorowski, Norbert H Brockmeyer, Oliver Overheu, Anke Reinacher-Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Ingo Schmitz, Anja Potthoff, Carlos Plaza-Sirvent J Eur Acad Dermatol Venereol. 13 March 2023  doi.org/10.1111/jdv.19036
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411  Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525 Skin cancer triage and management during COVID-19 pandemic Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB) J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16529 Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy) Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16473 Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model Tejera-Vaquerizo A, Nagore E J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16555 Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16586 European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557 Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593 Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus Balestri R, Rech G, Girardelli CR J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578 COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16625 Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16759 Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19 Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16838 Severe COVID-19 outcomes in patients with psoriasis Lima XT, Cueva MA, Lopes EM, Alora MB J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16867 Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879 Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey Dyrberg Loft N, Halling AS, Iversen L, Vestergaard C, Deleuran M, Rasmussen MK, Zachariae C, Thyssen JP, Skov L J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16863 Delayed Melanoma diagnosis in the Covid-19 era: increased Breslow thickness in primary Melanomas seen after the Covid-19 lockdown Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D. J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16874 Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy Santos VS, Quintans-Júnior LJ, de Souza Barboza W, Antunes de Souza Araújo A, Ricardo Martins-Filho P J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16899 Wearing a mask and facial skin diseases: patients with atopic dermatitis express themselves Stéphanie Merhand, Laurent Misery, Véronique Delvigne, Caroline Le Floch, Charles Taïeb J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16917 Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879 Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab Ferrucci SM, Tavecchio S, Favale EM, Angileri L, Riva D, Romagnuolo M, Beretta AE, Marzano AV J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16955 Immunological and virological profile of children with chilblain-like lesions shows no evident link with SARS-CoV-2 L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, J. Fourgeaud, S. Hadj‐Rabia, S. Temmam, M. Eloit, Sermet‐Gaudelus, C. Bodemer J Eur Acad Dermatol Venereol. 2020 Oct 3. doi.org/10.1111/jdv.16972 Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy Randolph, M, Al‐alola A, Tosti A J Eur Acad Dermatol Venereol. 2020 Oct 12. doi.org/10.1111/jdv.16989 COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data L.E.M. de Wijs M.M. Joustra J.I. Olydam T. Nijsten D.J. Hijnen J Eur Acad Dermatol Venereol. 2020 Nov 1 doi.org/10.1111/jdv.17025 COVID-19 and HHV8 first spotted together: an affair under electron microscopy E. Leoni M. Cerati G. Finzi M. Lombardo F. Sessa J Eur Acad Dermatol Venereol. 2021 18 Jan doi.org/10.1111/jdv.17123 Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation G.C. Gondo S.J. Bell J. Slayden G. Ullmann A. Blauvelt J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17173 Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? S. Piaserico P. Gisondi S. Cazzaniga G. Girolomoni P.G. Calzavara‐Pinton L. Naldi J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17175 COVID-19 and immune checkpoint inhibitors M.S. Ahmed H. Brehme S. Friedrich L. Reinhardt S. Blum S. Beissert F. Meier J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17172 Rapidly progressive Alopecia Areata Totalis in a Covid-19 patient, unresponsive to Tofacitinib S. Berbert Ferreira M.F.R. Gavazzoni Dias R. Berbert Ferreira A.C. Neves Neto R.M. Trüeb O. Lupi J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17170 Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments P. Gisondi D. Geat L. Naldi S. Piaserico J Eur Acad Dermatol Venereol. 2021 Mar 1 doi.org/10.1111/jdv.17200 COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation M. Kasperkiewicz M. Yale R. Strong D. Zillikens D.T. Woodley A. Recke J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17228 Risk of severe allergic reactions to Covid-19 vaccines among patients with allergic or inflammatory skin diseases – practical recommendations. A position statement of ETFAD with external experts J. Ring M. Worm A. Wollenberg J.P. Thyssen T. Jakob L. Klimek C. Bangert S. Barbarot T. Bieber M.S. de Bruin‐Weller P.V. Chernyshov S. Christen‐Zaech M. Cork U. Darsow C. Flohr R. Fölster‐Holst C. Gelmetti U. Gieler J. Gutermuth A. Heratizadeh D.J. Hijnen L.B. von Kobyletzki B. Kunz C. Paul L. De Raeve J. Seneschal D. Simon P.I. Spuls J.F. Stalder A. Svensson Z. Szalai A. Taieb A. Torrelo M. Trzeciak C. Vestergaard T. Werfel S. Weidinger M. Deleuran J Eur Acad Dermatol Venereol. 2021 March 22 doi.org/10.1111/jdv.17237 Vaccination Against SARS-COV-2 and PSORIASIS: the three things every dermatologist should know F. Diotallevi A. Campanati G. Radi E. Martina G. Rizzetto P Barbadoro M.M. D’Errico A. Offidani J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17256 Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study Jorge R. Georgakopoulos Asfandyar Mufti Ron Vender Vimal H. Prajapati Jensen Yeung J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17279 Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned? P. Sarkis J. Sarkis M. Alkassis J. Assaf K. El Gharib J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17287 Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance JM Busto‐Leis G Servera‐Negre A Mayor‐Ibarguren E Sendagorta‐Cudós M Feito‐Rodríguez A Nuño‐González MD Montero‐Vega P Herranz‐Pinto J Eur Acad Dermatol Venereol. 2021 Apr 26 doi/abs/10.1111/jdv.17301 Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19 C.C. Zouboulis J.A.M. van Laar M. Schirmer G. Emmi F. Fortune A. Gül Y. Kirino E.‐S. Lee P.P. Sfikakis F. Shahram G.R. Wallace J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17325 Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo J Eur Acad Dermatol Venereol. 2021 May 29 oi/full/10.1111/jdv.17409 Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials D. Thaçi, D. Jullien, A. Egeberg, J.M. Carrascosa, J.J. Wu, I. Pau-Charles, P. Gisondi J Eur Acad Dermatol Venereol. 2021 May 31 com/doi/10.1111/jdv.17427 Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh J Eur Acad Dermatol Venereol. 2021 May 12 com/doi/10.1111/jdv.17353 Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, Y. Peñate, E. Acebo, R. Fernández de Misa, M. Blanes, HJ. Suh-Oh, R. Izu, E. Silva-Díaz, J. Sarriugarte, C. Román-Curto, R. Botella-Estrada, A. Mateu-Puchades, L. Prieto-Torres, V. Morillas, Me. Morillo, P. Sanchez-Caminero, L. Calzado, A. Pérez-Ferriols, A. Pérez, JD. Domínguez, M. Navedo, C. Muniesa, A. Combalia, J. Arroyo-Andrés, MA. Descalzo, I. García-Doval, PL. Ortiz-Romero J Eur Acad Dermatol Venereol. 2021 Jun 1 com/doi/10.1111/jdv.17430 A review of nail findings associated with COVID-19 infection Edward Hadeler, Brian W. Morrison, Antonella Tosti J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17448 The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center R. Rrapi, S. Chand, J.A. Lo, C.K. Gabel, S. Song, Z. Holcomb, C. Iriarte, K. Moore, C.R. Shi, H. Song, F.D. Xia, D. Yanes, R. Gandhi, V.A. Triant, D. Kroshinsky J Eur Acad Dermatol Venereol. 2021 Jun 19 com/doi/10.1111/jdv.17459 Ulcus vulvae acutum and SARS-Co V-2: an etiological role? M.C. Alberelli, A. Panariello, M. Olivi, A. Borghi, P. Zedde, M. Corazza J Eur Acad Dermatol Venereol. 2021 Jun 21 oi/10.1111/jdv.17463?af=R Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa-Araya, Consuelo Cárdenas, Juan Camilo Castro, Francisco Dominguez, Katherine Droppelmann, Nicolás Droppelmann, Héctor Galindo, Augusto León, Jorge Madrid, Montserrat Molgó, Sebastián Mondaca, Pablo H. Montero, Pablo Uribe, Miguel A. Villaseca, Eugenio Vinés, Cristian Navarrete-Dechent J Eur Acad Dermatol Venereol. 2021 Jul 14 oi/full/10.1111/jdv.17522 Impact of the COVID-19 pandemic on melanoma diagnosis P. Gisondi, S. Cazzaniga, S. Di Leo, S. Piaserico, F. Bellinato, M. Pizzolato, A. Gatti, A. Eccher, M. Brunelli, D. Saraggi, G. Girolomoni, L. Naldi J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17493 The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities Clio Dessinioti, Claus Garbe, Alexander J Stratigos J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17552 COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria P.R. Criado,M. Ianhez,C.C. Silva de Castro,C. Talhari,P.M. Ramos,H.A. Miot J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17635 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study Y. Lytvyn,J.R. Georgakopoulos,A. Mufti,A.R. Devani,M.J. Gooderham,V. Jain,P. Lansang,R. Vender,V.H. Prajapati,J. Yeung J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17749 Impact of the French COVID-19 pandemic lockdown on new melanoma diagnosis delay and severity R. Molinier,A. Roger,B. Genet,A. Blom,C. Longvert,L. Chaplain,M. Fort,P. Saiag,E. Funck-Brentano jdv.17802 Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs A. Cristaudo,D. Graceffa,F. Pimpinelli,F. Sperati,G. Spoletini,C. Bonifati,R. Pellini,V. Lora,M. Pontone,O. Di Bella,D. Bracco,A. Morrone J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17861 Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes U. Rakita,T. Kaundinya,A. Guraya,K. Nelson,B. Maner,J. Manjunath,G. Schwartzman,B. Lane,J.I. Silverberg J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17825 Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant A. Giannattasio,M. Rosa,S. Esposito,O. Di Mita,F. Angrisani,S. Acierno,C. D’Anna,F. Barbato,V. Tipo,O. Ametrano J Eur Acad Dermatol Venereol. 2021 Dec 4 doi.org/10.1111/jdv.17850 Primitive Melanoma and Covid 19 are we still paying the price of the pandemic? F. Ricci,G. Di Lella,L. Fania,F. Ricci,L. Sobrino,S. Pallotta,A. Panebianco,C. Fortes,D. Abeni J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17892 High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection B. Mille,S. Ingen-Housz-Oro,N. De Prost,G. Voiriot,A. Soria,F. Tetart,C. Bernier,C. Morice,D. Staumont-Salle,F. Dezoteux,(“French Investigator for Skin Adverse Reaction to Drugs”) J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17885 The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays E. Slotman,K. Schreuder,T.E.C. Nijsten,M. Wakkee,L. Hollestein,A. Mooyaart,S. Siesling,M.W.J. Louwman J Eur Acad Dermatol Venereol. 2022 Jan 28 doi.org/10.1111/jdv.17976 Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature G. Licata,D. Buononato,C. Fiorentino,G. Calabrese,A. De Rosa,G. Argenziano,A. Gambardella J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17913 Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients L. Potestio,M. Napolitano,L. Bennardo,G. Fabbrocini,C. Patruno J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17964 Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco H. Kerrouch,M. Khalidi,R. Frikh,N. Hjira,M. Boui J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18057 Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience L. Stingeni,L. Bianchi,E. Antonelli,E.S. Caroppo,S.M. Ferrucci,M. Ortoncelli,G. Fabbrocini,E. Nettis,D. Schena,M. Napolitano,M. Gola,L. Bonzano,M. Rossi,A. Belloni Fortina,A. Balato,K. Peris,C. Foti,F. Guarneri,M. Romanelli,C. Patruno,P. Savoia,M.C. Fargnoli,F. Russo,E. Errichetti,T. Bianchelli,L. Bianchi,G. Pellacani,C. Feliciani,A. Offidani,M. Corazza,G. Micali,N. Milanesi,G. Malara,A. Chiricozzi,M. Tramontana,K. Hansel,DADA – Dupilumab for Atopic Dermatitis of the Adolescence Study Group J Eur Acad Dermatol Venereol. 2022 Apr 12 doi.org/10.1111/jdv.18141 Impact of containment and social distancing on the number of community-acquired Staphylococcus aureus skin infections P. Del Giudice,J. Gillon,L. Roudiere,M. Reverte J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18111 Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy S. Caini,M. Brusasco,G. Niero,V. De Giorgi,M. Lombardo,C. Massone,M. Medri,G. Palmieri,M.A. Pizzichetta,P. Quaglino,R. Satta,C. Feliciani,S. Gandini,I. Stanganelli,Italian Melanoma Intergroup (IMI), Italian Association of Melanoma Patients (AIMaMe) J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18056 Non-allergic nature of vast majority of cutaneous adverse reactions to mRNA COVID-19 vaccines: implications on treatment and re-vaccination T. Ju,S.Y.D. Lim,G. Yosipovitch,H.L. Tey J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16989 Long-term effects of the COVID-19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics G. Balakirski,A.-L. Michalowitz,A. Kreuter,S.C. Hofmann J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16972 Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event Michael Kasperkiewicz J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16411 A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection C. Colonna,S. Giacalone,M. Zussino,N.A. Monzani,S. Cambiaghi,R. Cavalli J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16525 Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient E. Gimeno,D. Morgado-Carrasco,D. Moriscot,J. Piquero-Casals J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16529 Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection T. Gambichler,C.H. Scheel,Y. Arafat,O. Kautz,S. Boms J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16473 Allergic reaction to red cosmetic lip tattoo with possible exacerbations after SARS-CoV-2 vaccination N. Kluger J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16555 Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 cases A. Mohta,M. K. Sharma J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16586 Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis C. Washrawirul,J. Triwatcharikorn,J. Phannajit,M. Ullman,P. Susantitaphong,P. Rerknimitr J Eur Acad Dermatol Venereol. 2022 June 06 doi.org/10.1111/jdv.16557 Generalized morphea after COVID-19 vaccines: a case series G. Paolino,C. Campochiaro,M.R. Di Nicola,S.R. Mercuri,N. Rizzo,L. Dagna,F. Rongioletti,G. De Luca J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16593 Complete remission of primary cutaneous follicle centre cell lymphoma associated with COVID-19 vaccine S. Aouali,M. Benkaraache,Y. Almheirat,N. Zizi,S. Dikhaye J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16578 Maskne prevalence and risk factors during the COVID-19 pandemic A. Villani,G. Fabbrocini,M.C. Annunziata,L. Potestio J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16625 Efficacy of low-dose methotrexate in a short-regimen for granulomatous sarcoid-like reaction on permanent make-up during COVID-19 infection N. Kluger,V. Descamps J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16625 Nail psoriasis: a rare mRNA COVID-19 vaccine reaction A. Lamberti,V. Lora,D. Graceffa,C. Bonifati,C. Cota J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16759 A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford–AstraZeneca COVID-19 vaccine F. Filippi,C. Baraldi,P.L. Zinzani,B. Casadei,A. Pileri J Eur Acad Dermatol Venereol. 2022 May 26 doi.org/10.1111/jdv.16838 Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine) M. Daldoul,M. Korbi,A. Bellalah,N. Ben Fadhel,H. Belhadjali,J. Zili J Eur Acad Dermatol Venereol. 2022 May 23 doi.org/10.1111/jdv.16867 Hansen’s disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic P. Deps,S.M. Collin,V.L.G. de Andrade J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16879 New onset of sarcoidosis after COVID-19 infection A. Rabufetti,L. Borradori,K. Heidemeyer,L. Feldmeyer,R.E. Hunger,N. Yawalkar,S.M. Seyed Jafari J Eur Acad Dermatol Venereol. 2022 June 10 doi.org/10.1111/jdv.16863 Reply to ‘Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2’ by Solimani et al F. Martora,G. Fabbrocini,P. Nappa,M. Megna J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16874 Erythema nodosum following SARS-CoV-2 vaccine Y. Xie,B. Yin,X. Shi J Eur Acad Dermatol Venereol. 2022 June 09 doi.org/10.1111/jdv.16899 Types and prevalence of adverse skin reactions associated with prolonged N95 and simple mask usage during the COVID-19 pandemic A.R. Darnall,D. Sall,C. Bay J Eur Acad Dermatol Venereol. 2022 June 24 doi.org/10.1111/jdv.16917 Hand–foot syndrome like eruption following mRNA COVID-19 vaccine M. Daldoul,M. Korbi,N. Ben Salah,A. Bellalah,H. Belhadjali,J. Zili J Eur Acad Dermatol Venereol. 2022 June 28 doi.org/10.1111/jdv.16879 Scabies revisited in the COVID-19 era I. Trave,A. Muracchioli,E. Cozzani,A. Parodi J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16955 Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry) J. Zitouni,A.-C. Bursztejn,A. Belloni Fortina,A. Beauchet,V. Di Lernia,A. Lesiak,J. Thomas,Z. Topkarci,N. Murashkin,P. Brzezinski,T. Torres,A. Chiriac,C. Luca,T. McPherson,M. Akinde,A. Maruani,R. Epishev,H. Vidaurri de la Cruz,P.C. Luna,M. Amy de la Bretêque,A. Lasek,E. Bourrat,M. Bachelerie,S. Mallet,M. Steff,A. Bellissen,I. Neri,E. Zafiriou,J.M.P.A. van den Reek,E. Sonkoly,S.K. Mahil,C.H. Smith,C. Flohr,H. Bachelez,E. Mahé,the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BPSD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.) J Eur Acad Dermatol Venereol. 2022 June 24 doi.org/10.1111/jdv.18361 Reactions in leprosy patients triggered by COVID-19 vaccination – a cross-sectional study from a tertiary care centre in India A. Bhandari,Shilpa,S. Gupta,S. Dogra,T. Narang J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18390 Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic Maria Jose Monroy-Iglesias,Hajer Hadi,Beth Russell,Charlotte Moss,Lucy Flanders,Saoirse Dolly,Sophie Papa,Mieke Van Hemelrijck J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18514 Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation Michael Kasperkiewicz,Rebecca Strong,Marc Yale,Patrick Dunn,David T. Woodley J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18493 Reply to ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al. Angelo Ruggiero,Fabrizio Martora,Fabrizio Fornaro,Massimiliano Scalvenzi,Gabriella Fabbrocini,Alessia Villani J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18512 Reply to A. Ruggiero et al. to our article ‘Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity’ Rafaele Molinier,Anissa Roger,Bastien Genet,Philippe Saiag,Elisa Funck-Brentano J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18542 Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies Michael Kasperkiewicz, David T. Woodley J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18538 Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study Giuseppe Stinco, Enzo Errichetti, Matteo Figini, Alba Guglielmo, Benedetta Fazzi, Luca Quartuccio, Alen Zabotti, Salvatore De Vita, Miriam Isola, Maria De Martino, Silvia Rossi, Riccardo Lucis, Martina Fabris, Antonio Paolo Beltrami, Francesco Curcio, Federica D’Aurizio J Eur Acad Dermatol Venereol. 2022 December 07 doi.org/10.1111/jdv.18809 Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan, Eleftheria Chorti, Dirk Schadendorf, Selma Ugurel, Alexander Roesch, Ingo Stoffels, Joachim Klode J Eur Acad Dermatol Venereol. 2023 January 06 doi.org/10.1111/jdv.18847 Interplay between Adamantiades-Behçet’s disease and COVID-19 – a case series from the German registry of Adamantiades-Behçet’s disease Anthony Lim, Andreas Altenburg, Christos C. Zouboulis J Eur Acad Dermatol Venereol. 03 February 2023 doi.org/10.1111/jdv.18939 Heterologous versus homologous primary and booster COVID-19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real-life, multicenter, case–control study Santo Raffaele Mercuri, Alessia Pacifico, Piergiorgio Malagoli, Vittoria Giulia Bianchi, Fabrizio Ernesto Pregliasco, Massimo Del Fabbro, Giovanni Damiani J Eur Acad Dermatol Venereol.  03 February 2023  doi.org/10.1111/jdv.18943 Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination Thilo Gambichler J Eur Acad Dermatol Venereol. 13 March 2023  doi.org/10.1111/jdv.19046 SARS-CoV-2 vaccination status and adverse events among patients with psoriasis—Data from the German Registries PsoBest and CoronaBest María José Valencia López, Anna Meineke, Brigitte Stephan, Stephan Jeff Rustenbach, Anne Kis, Diamant Thaçi, Ulrich Mrowietz, Kristian Reich, Petra Staubach-Renz, Ralph von Kiedrowski, Henriette Bogena, Matthias Augustin J Eur Acad Dermatol Venereol. 13 March 2023  doi.org/10.1111/jdv.19039 Increased risk of COVID-19-related hospitalization in patients with hidradenitis suppurativa Jonathan Koptyev, Andrew Strunk, Amit Garg J Eur Acad Dermatol Venereol. 13 March 2023  doi.org/10.1111/jdv.19033 Impact of COVID-19 in patients with autoimmune bullous diseases: report from an international registry Joost M. Meijer, Hanan Rashid, Styliani Vergadi, Emiliano Antiga, Pamela Vezzoli, Riccardo Balestri, Aikaterini Patsatsi, Soner Uzun, Dusan Skiljevic, Hana Jedlickova, Lucia Janickova, Alberto Corrà, Alessandra Ponziani, Claudia Günther, Giuseppe Cianchini, Matthias Schefzyk, Angelo Marzano, Giovanni Di Zenzo, Iakov Shimanovich, Janet Fairley, Jose M. Mascaró Jr, Marzia Caproni, Roberto Maglie, Enno Schmidt, Barbara Horváth J Eur Acad Dermatol Venereol. 08 June 2023 doi.org/10.1111/jdv.19242 Gianotti-Crosti syndrome following Covid-19 infection M. Ben Kahla, J. Rouatbi, N. Ghariani Fetoui, A. Aounallah, B. Sriha, C. Belajouza, N. Ghariani, S. Mokni, M. Lahouel, M. Denguezli J Eur Acad Dermatol Venereol. 17 July 2023 doi.org/10.1111/jdv.19343 The Gabrin Sign’s Potential for Identifying High-Risk Patients for COVID-19 with Androgenic Alopecia Alpana Mohta, Sumiti Pareek, Vijeta Prasad, Achala Mohta, Asha Nyati J Eur Acad Dermatol Venereol. 14 Sep 2023 doi.org/10.1111/jdv.19514 Cutaneous Tuberculosis and its possible association with COVID-19 Neerja Saraswat, Durga Madhab Tripathy, Abhishek Mishra, Sushil Kumar, Shobhit Goel J Eur Acad Dermatol Venereol. 31 Oct 2023 doi.org/10.1111/jdv.19592 Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: insights from a survey Nikolaj Holgersen, Valdemar W. Nielsen, Zarqa Ali, Mette Brøgger-Mikkelsen, Marius M. Flege, Jacob P. Thyssen, Alexander Egeberg, Simon F. Thomsen J Eur Acad Dermatol Venereol. 18 December 2023 doi.org/10.1111/jdv.19758

Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy
S. Caini,M. Brusasco,G. Niero,V. De Giorgi,M. Lombardo,C. Massone,M. Medri,G. Palmieri,M.A. Pizzichetta,P. Quaglino,R. Satta,C. Feliciani,S. Gandini,I. Stanganelli,Italian Melanoma Intergroup (IMI), Italian Association of Melanoma Patients (AIMaMe)
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18056

Skin cancer and COVID-19: was the diagnosis safeguarded by teledermatology? a study on 1229 cases

C. Skayem,C. Hua,O. Zehou,A. Jannic, A. Viarnaud,P. Wolkenstein,T.A. Duong
J Eur Acad Dermatol Venereol. 2022 Apr 20 doi.org/10.1111/jdv.16905

Impact of SARS-CoV-2 infection in children with psoriasis: Results of a monocentric experience

Francesca Caroppo, Laura Fagotto, Jacopo Tartaglia, Roberto Mazzetto, Anna Belloni Fortina
J Eur Acad Dermatol Venereol. 17 January 2023 doi.org/10.1111/jdv.18874

Further Reading

JEADVCovid 19 Special Forum

WHOPublic advice, country and technical guidance, updates on Coronavirus disease

CDCPrecautions and guidance during COVID-19

American Academy of DermatologyCoronavirus Resource Center: Resources to help protect patients and practice

British Association of Dermatologists Statement on the management of higher risk dermatology patients during COVID-19

Academia Española de Dermatología y VenereologíaDermatologists advice, technical guidance, updates on Coronavirus disease

Société Française de DermatologieCOVID-19 Advice from the French Society of Dermatology

Italian Society of DermatologyThe SIDeMaST Vademecum: How to behave in the Coronavirus emergency

Royal Belgian Society for Dermatology and VenereologyDermanet: The latest information on the COVID-19

Deutsche Dermatologische GesellschaftCOVID-19 Advice from the German Dermatological Society

Finnish Institute for Health and WelfareTHL Network for prevention and control of infectious diseases

International League of Dermatological societiesGuidance on the practice of dermato surgery and cosmetic procedures, and the use of systemic therapy for patients with psoriasis/atopic dermatitis during coronavirus outbreak.

European society for medical oncologyESMO Statements: Helping oncology professionals deliver optimal care to their cancer patients

European League Against RheumatismEULAR guidance and useful resources on management of patients with Rheumatic Musculoskeletal diseases (RMDs) to provide the best possible care during the pandemic COVID-19

Filière de santé des maladies auto immunes et auto-inflammatoires raresManagement of patients with auto immune or inflammatory diseases during COVID-19

European reference Networks/Orphanet rare diseasesRecommendations and services concerning COVID-19 and rare diseases

Agence nationale de sécurité du médicament et des produits de santéManagement of dermatology patients enrolled in ongoing clinical trials during COVID-19 – English version of the French recommendations

The German Psoriasis-RegistryRecommendations for systemic therapy in people with psoriasis during the pandemic phase of SARS-CoV-2

International Psoriasis CouncilStatement on the Coronavirus Outbreak

British Association for Sexual Health and HIV, in collaboration with NHSUseful resources for the European situation on social distancing and provision of sexual services to the community

Robert Koch InstituteInformation, articles and material from the Robert Koch Institut, Berlin

International prospective register of systematic reviewsFast-tracking registration of protocols related to COVID-19 (for systematic, rapid and umbrella reviews).

MedRxiv and BioRxivCOVID-19 SARS-CoV-2 preprints from MedRxiv and BioRxiv.

Cochrane COVID-19 Study RegisterCoronavirus (COVID-19) – Cochrane resources and news.

Internationa Clinical Trials RegistriesDatabase of privately and publicly funded clinical studies conducted around the world.

Lit CovidLiterature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus.

TRIP DatabaseEvidence-based search engine to help health professionals find trustworthy answers to their COVID clinical questions.

EpistemonikosEvidence-based answers for the most frequent questions regarding the COVID emergency.

Only trust information from our official website: eadv.org | Copyright 2024 EADV